- Recommendation ID
- TA236/2
- Question
- Further research into whether ticagrelor is particularly beneficial in any clinical or biological subgroups would be useful.
- Any explanatory notes
(if applicable) - None.
Source guidance details
- Comes from guidance
- Ticagrelor for the treatment of acute coronary syndromes
- Number
- TA236
- Date issued
- October 2011
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |